SpiroChem Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 120

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $605K

  • Investors
  • 3

SpiroChem General Information

Description

Operator of a discovery and chemistry contract research organization intended to accelerate drug discovery and lead optimization programs. The company offers proprietary screening of covalent fragments and macrocycles, fragment-based drug designing, and computational-aided drug design services, enabling the biotechnology, pharmaceutical, agrochemical, and life science companies to speed up research programs and explore uncharted chemical space.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rosental Area, WRO-1047-3
  • Mattenstrasse 22
  • 4058 Basel
  • Switzerland
+41 061
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Agriculture
Drug Discovery
Vertical(s)
Corporate Office
  • Rosental Area, WRO-1047-3
  • Mattenstrasse 22
  • 4058 Basel
  • Switzerland
+41 061

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SpiroChem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 21-Jun-2021 $605K Completed Generating Revenue
5. Later Stage VC 13-Dec-2017 Completed Startup
4. Grant 26-Jan-2016 Completed Startup
3. Seed Round 10-Sep-2013 Completed Startup
2. Grant 25-May-2011 $11.4K Completed Startup
1. University Spin-Out 01-Jan-2011 Completed Startup
To view SpiroChem’s complete valuation and funding history, request access »

SpiroChem Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
To view SpiroChem’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

SpiroChem Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a discovery and chemistry contract research organization intended to accelerate drug discovery and lead opti
Other Pharmaceuticals and Biotechnology
Basel, Switzerland
120 As of 2026

Kaiseraugst, Switzerland
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

SpiroChem Competitors (11)

One of SpiroChem’s 11 competitors is Solvias, a Private Equity-Backed company based in Kaiseraugst, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Solvias Private Equity-Backed Kaiseraugst, Switzerland
Crown Bioscience Formerly VC-backed San Diego, CA
Buffalo Biolabs Corporation Buffalo, NY
Taconic Biosciences Private Equity-Backed Rensselaer, NY
Charles River Laboratories International Formerly PE-Backed Wilmington, MA
You’re viewing 5 of 11 competitors. Get the full list »

SpiroChem Patents

SpiroChem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240051933-A1 Urolithin derivatives and therapeutic uses Pending 27-Jul-2022
US-11820751-B2 Urolithin derivatives and methods of use thereof Active 27-Jan-2021
US-12351567-B2 Urolithin derivatives and methods of use thereof Active 27-Jan-2021
US-12358884-B2 Urolithin derivatives and methods of use thereof Active 27-Jan-2021
US-20220259173-A1 Urolithin derivatives and methods of use thereof Active 27-Jan-2021 C07D311/80
To view SpiroChem’s complete patent history, request access »

SpiroChem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SpiroChem Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Swiss Government Government
Venture Kick Accelerator/Incubator
ETH Zurich University
To view SpiroChem’s complete investors history, request access »

SpiroChem Acquisitions (1)

SpiroChem’s most recent deal was a Merger/Acquisition with Cyclenium Pharma. The deal was made on 06-Jun-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cyclenium Pharma 06-Jun-2023 Merger/Acquisition Other Pharmaceuticals and Biotechnology
To view SpiroChem’s complete acquisitions history, request access »

SpiroChem Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Cyclenium Pharma Montreal, Canada 2013

SpiroChem FAQs

  • When was SpiroChem founded?

    SpiroChem was founded in 2011.

  • Where is SpiroChem headquartered?

    SpiroChem is headquartered in Basel, Switzerland.

  • What is the size of SpiroChem?

    SpiroChem has 120 total employees.

  • What industry is SpiroChem in?

    SpiroChem’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is SpiroChem a private or public company?

    SpiroChem is a Private company.

  • What is the current valuation of SpiroChem?

    The current valuation of SpiroChem is .

  • What is SpiroChem’s current revenue?

    The current revenue for SpiroChem is .

  • How much funding has SpiroChem raised over time?

    SpiroChem has raised $1.03M.

  • Who are SpiroChem’s investors?

    Swiss Government, Venture Kick, and ETH Zurich have invested in SpiroChem.

  • Who are SpiroChem’s competitors?

    Solvias, Crown Bioscience, Buffalo Biolabs, Taconic Biosciences, and Charles River Laboratories International are some of the 11 competitors of SpiroChem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process